Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Grant/Award of 22,350 OKUR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 22,350 | n/a |
| Jun 8, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| Aug 14, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,781 | n/a |
| May 30, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 7,650 | n/a |
| May 7, 2025 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 5,209 | n/a |
| Oct 16, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 70,000 | $49.7K |
| Oct 8, 2024 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 874 | n/a |
| Sep 24, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Exercise/Conversion | 46,068 | $88.9K |
| Aug 14, 2024 | Edgewise Therapeutics, Inc. (EWTX) | Grant/Award | 138,750 | n/a |
| Jun 17, 2024 | Elevation Oncology, Inc. (ELEV) | Grant/Award | 35,000 | n/a |